8.51
price up icon1.79%   0.15
pre-market  Vorhandelsmarkt:  8.63   0.12   +1.41%
loading

Kamada Ltd Aktie (KMDA) Neueste Nachrichten

pulisher
Feb 11, 2026

Weekly Earnings: Is Kamada Ltd stock a buy or sellWeekly Earnings Recap & Intraday High Probability Setup Alerts - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 05, 2026

Sentiment Review: Is Kamada Ltd exposed to political riskCEO Change & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 04, 2026

Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

Is Kamada Ltd exposed to political riskWeekly Trading Summary & AI Powered Market Entry Strategies - baoquankhu1.vn

Feb 04, 2026
pulisher
Feb 01, 2026

Aug Intraday: Can Kamada Ltd navigate macro headwindsPortfolio Return Report & Daily Profit Maximizing Tips - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 28, 2026

Kamada (TLV:KMDA) shareholder returns have been favorable, earning 74% in 3 years - simplywall.st

Jan 28, 2026
pulisher
Jan 28, 2026

Can Kamada Ltd. continue delivering strong returnsJuly 2025 Gainers & Verified Chart Pattern Signals - mfd.ru

Jan 28, 2026
pulisher
Jan 27, 2026

Pharma News: Will Kamada Ltd outperform the market in YEAR2025 Short Interest & Weekly Top Stock Performers List - baoquankhu1.vn

Jan 27, 2026
pulisher
Jan 27, 2026

Kamada (KMDA) Soars 8.1%: Is Further Upside Left in the Stock? - Yahoo Finance

Jan 27, 2026
pulisher
Jan 25, 2026

Volume Summary: Is Kamada Ltd a potential multi baggerTrade Entry Summary & Reliable Breakout Stock Forecasts - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 23, 2026

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 62.91% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews

Jan 23, 2026
pulisher
Jan 22, 2026

Kamada Ltd: Biopharma under Pressure as KMDA Stock Tests Investor Patience - AD HOC NEWS

Jan 22, 2026
pulisher
Jan 20, 2026

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market - openPR.com

Jan 20, 2026
pulisher
Jan 20, 2026

Is Kamada Ltd. stock a safe investment in uncertain marketsSector ETF Performance & Fast Growing Trading Plans - Bollywood Helpline

Jan 20, 2026
pulisher
Jan 16, 2026

Kamada Ltd. (KMDA) Stock Analysis: Exploring A 58.15% Upside In The Healthcare Space - DirectorsTalk Interviews

Jan 16, 2026
pulisher
Jan 13, 2026

Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio | Corporate - EQS News

Jan 13, 2026
pulisher
Jan 13, 2026

Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio - NewMediaWire

Jan 13, 2026
pulisher
Jan 13, 2026

Kamada Projects Strong 2026 Growth Fueled by Plasma Portfolio and Distribution Expansion - citybuzz -

Jan 13, 2026
pulisher
Jan 12, 2026

Kamada shares climb after upbeat 2026 outlook points to double-digit growth - MSN

Jan 12, 2026
pulisher
Jan 12, 2026

HC Wainwright Issues Optimistic Forecast for Kamada Earnings - Defense World

Jan 12, 2026
pulisher
Jan 10, 2026

Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN

Jan 10, 2026
pulisher
Jan 10, 2026

Q1 Earnings Forecast for Kamada Issued By HC Wainwright - Defense World

Jan 10, 2026
pulisher
Jan 09, 2026

Kamada Ltd. (KMDA) Stock Analysis: Unpacking a 63.52% Potential Upside in Healthcare Innovation - DirectorsTalk Interviews

Jan 09, 2026
pulisher
Jan 09, 2026

Q1 Earnings Estimate for Kamada Issued By HC Wainwright - MarketBeat

Jan 09, 2026
pulisher
Jan 08, 2026

Can Kamada Ltd. stock attract ESG capital inflowsMarket Performance Recap & Low Drawdown Momentum Trade Ideas - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Benchmark reiterates Buy rating on Kamada stock, maintains $15 target By Investing.com - Investing.com Nigeria

Jan 08, 2026
pulisher
Jan 08, 2026

Benchmark reiterates Buy rating on Kamada stock, maintains $15 target - Investing.com

Jan 08, 2026
pulisher
Jan 08, 2026

Kamada 2025/2026 Outlook: Evaluating Revenue Growth And Product Drivers (NASDAQ:KMDA) - Seeking Alpha

Jan 08, 2026
pulisher
Jan 07, 2026

Kamada (KMDA) Projects Strong Revenue and EBITDA Growth by 2026 - GuruFocus

Jan 07, 2026
pulisher
Jan 07, 2026

Kamada forecasts double-digit profitable growth in 2026 - MSN

Jan 07, 2026
pulisher
Jan 07, 2026

Kamada stock rises after issuing 2026 guidance showing double-digit growth - Investing.com Nigeria

Jan 07, 2026
pulisher
Jan 07, 2026

Kamada stock rises after issuing 2026 guidance showing double-digit growth By Investing.com - Investing.com South Africa

Jan 07, 2026
pulisher
Jan 07, 2026

Kamada forecasts 13% revenue growth in 2026, issues guidance - Investing.com

Jan 07, 2026
pulisher
Jan 07, 2026

Kamada forecasts 13% revenue growth in 2026, issues guidance By Investing.com - Investing.com Nigeria

Jan 07, 2026
pulisher
Jan 07, 2026

Kamada Provides 2026 Annual Guidance of $200$205 Million in Revenues and $50$53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance - marketscreener.com

Jan 07, 2026
pulisher
Jan 06, 2026

Kamada (NASDAQ:KMDA) Stock Crosses Above 50 Day Moving AverageHere's Why - MarketBeat

Jan 06, 2026
pulisher
Jan 02, 2026

Kamada Ltd. (KMDA) Stock Analysis: Unearthing an 84% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews

Jan 02, 2026
pulisher
Jan 01, 2026

Leasing LimitedFundamental Strength Indicators & Free Exceptional ROI Methods - bollywoodhelpline.com

Jan 01, 2026
pulisher
Dec 23, 2025

Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving AverageTime to Sell? - MarketBeat

Dec 23, 2025
pulisher
Dec 23, 2025

Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving Average – Time to Sell? - Defense World

Dec 23, 2025
pulisher
Dec 23, 2025

Kamada (KMDA) price target decreased by 11.86% to 13.26 - MSN

Dec 23, 2025
pulisher
Dec 22, 2025

Kamada (KMDA) Stock Analysis Report | Financials & Insights - Benzinga

Dec 22, 2025
pulisher
Dec 21, 2025

Kamada Ltd.(NasdaqGS: KMDA) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 21, 2025
pulisher
Dec 20, 2025

Is Kamada Ltd. stock affected by interest rate hikesInsider Selling & Long-Term Growth Plans - Улправда

Dec 20, 2025
drug_manufacturers_specialty_generic RDY
$14.21
price up icon 1.21%
$25.71
price up icon 0.39%
drug_manufacturers_specialty_generic RGC
$26.72
price up icon 0.15%
$137.44
price down icon 0.15%
$16.13
price up icon 1.13%
$475.85
price up icon 0.56%
Kapitalisierung:     |  Volumen (24h):